期刊名称:INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

ISSN:0268-1315
版本:SCI-CDE
出版频率:Bi-monthly
出版社:LIPPINCOTT WILLIAMS & WILKINS, TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, USA, PA, 19103
  出版社网址:http://www.lww.com/
期刊网址:http://journals.lww.com/intclinpsychopharm/pages/default.aspx
影响因子:1.659
主题范畴:PHARMACOLOGY & PHARMACY;    PSYCHIATRY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

Journal Information

International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes.

A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV. Other topics covered include the epidemiology of psychotropic drug prescribing and drug taking, the sociology of psychotropic drugs including compliance, and research into the safety and adverse effects of these compounds.


Instructions to Authors
  • Original research reports
  • Case reports and Short reports
  • Reviews
  • Commentaries

    CASE REPORTS and SHORT REPORTS should be no more than 1,500 words and 2 tables or figures. Please contact the Editor to discuss the suitability of topics for REVIEW - up to 7,500 words, COMMENTARY - up to 2,500 words, or other material falling outside the usual categories.

    Submission of Manuscripts:
    Manuscripts should be sent to the editor at the following address:
    Professor S A Montgomery
    International Clinical Psychopharmacology
    P.O. Box 8751
    London W13 8WH
    England
    Fax: +44 (0) 181 566 7986
    E-mail: ICP@montgomery.demon.co.uk

    Please submit four hard copies, typewritten, double spaced with wide margins ¡ª keep a copy for yourself ¡ª and one electronic copy on 3.59 disk. Please use IBM-compatible disks and state which word-processing software was used in preparation of the manuscript. After an article has been accepted for publication, the final version should be provided in machine readable form with a hard copy exactly the same as the data on disk.

    Conflict of Interest
    Authors are expected to disclose any commercial or other associations that might pose a conflict of interest in connection with the submitted article. All funding sources supporting the work, and institutional or corporate affiliations of the authors, should be acknowledged on the title page. Articles are considered for publication on the understanding that neither the article nor its essential substance has been or will be published elsewhere before appearing in International Clinical Psychopharmacology. Abstracts and press reports published in connection with scientific meetings are not considered to be publications.

    Permissions
    Materials copied from other sources must be accompanied by a written statement from both author and publisher giving permission to International Clinical Psychopharmacology for reproduction. Obtain permission in writing from at least one author of papers still in press, of unpublished data, and of personal communications. It is the author's responsibility to ensure that permissions are obtained.

    Arrangement of Manuscripts
    Preface each paper with a suitable title, the author(s) name(s), and the full address of the institution in which the work was carried out (please identify the author for proofs ¡ª giving telephone, fax and E-mail numbers ¡ª for correspondence and reprint requests), an abstract of no more than 200 words, and up to 8 keywords. Research reports should give an appropriate introduction, a single methods section (with the methodology of all experiments reports), results, and discussion. Either British or American spellings are acceptable, but please be consistent.

    Authors should express measurements in SI units, although they may include older conventional units in parentheses if they wish. Except for units of measurement, abbreviations should be spelled out on first use, and should be standard. Drug names should be generic, although authors may add brand names in parentheses if they wish.

    Illustrations should be lightly numbered on the back in pencil, with orientation and your name. We prefer glossy photographs or professionally prepared line drawings; any lettering and symbols must be large enough to stand reduction in size ¡ª publication could be delayed if lettering or symbols are too small. For halftones send unmounted glossy photographs with explanatory legends on a separate sheet of paper. Please send one set of photographs and attach a set of photocopies to each copy of the manuscript.

    The cost of reproducing colour illustrations is charged to the authors. Please contact the publishers for an estimate of this cost.

    Tables should bear Arabic numerals and be typed on separate sheets of paper. Each table requires a title, but no legend; identify footnotes by superscripts 1, 2, 3, etc.

    References follow the Harvard system. In the text give the author(s) name and, in parentheses, the date of the paper/book being cited. Differentiate between papers by the same author in the same year by a, b, c, etc., immediately after the date. Where there are three or more authors use et al. in the text and a, b, c to resolve ambiguities. All works cited must be listed at the end of the paper, ordered alphabetically by first author's name. For each first author, list single author works, next joint authored works in alphabetical order, last multi-authored works in chronological order. Each reference should give the names and initials of each author, the year of publication, the title of the paper, the name of the journal or book in full, the volume or edition, the first and last page, and, for books, the publisher and city of publication. For example:

    Smith AB, Brown CR, Jones XYZ (1992) Title etc. Int Clin Psychopharmacol 6:219¨C226.

    Trimble MR, Rogers D (1987) Neurological Disorder and schizophrenia. In: Handbook of Schizophrenia. Vol. 2. Neurochemistry and Neuropharmacology of Schizophrenia (FA Henn, LE DeLisi, eds), Amsterdam: Elsevier. pp. 439¨C465.

    Wechsler D (1984). Wechsler Memory Scale ¨C Revised. New York: Psychological Corporation.

    Ethical Policy
    When reporting research on human subjects, the work must comply with the principles of the Declaration of Helsinki (1964), and authors should indicate that ethical approval of the study was granted, and, where appropriate, that informed consent was given. The editor reserves the right to reject a paper with questionable ethical justification.

    Proofs, Reprints and Copyright
    Authors will normally be sent page proofs by fax where available. Such corrections as are necessary should be listed in the form of a table, with the location of the correction in the left hand column and the correction required in the right hand column. This table should be faxed to the Publishers within three days of proof receipt. Alterations, other than essential corrections to the text of the paper, should not be made at this stage; the cost of such alterations may be passed on to the author. A form for ordering reprints will be supplied with the proofs and should be returned direct to the Publisher. Manuscripts are accepted for publication on the understanding that exclusive copyright is assigned to the Publishers. However, this does not limit the freedom of the author(s) to use material in the papers in any other published works.


  • Editorial Board

     

    JOINT EDITORS

    Professor Stuart A Montgomery
    St Mary's Hospital Medical School
    London, UK

    Professor Martin B Keller
    Brown University
    Providence, USA


    FOUNDING EDITOR

    Professor Trevor Silverstone
    University of Otago
    Dunedin, New Zealand


    MANAGING EDITOR

    Deirdre Montgomery
    St Mary's Hospital Medical School
    London, UK


    ADDRESS ALL MANUSCRIPTS AND CORRESPONDENCE TO:

    Professor S A Montgomery
    International Clinical Psychopharmacology
    P.O. Box 8751
    London W13 8WH
    UK
    Fax: +44(0)20 8566 7986
    E-mail: ICP@samontgomery.co.uk

    EDITORIAL BOARD
    C Altamura
    University of Milan
    Italy

    T Barnes
    Imperial College School of Medicine
    London, UK

    M Bourin
    Universit¨¦ de Nantes
    France

    G D Burrows
    University of Melbourne
    Victoria, Australia

    G B Cassano
    University of Pisa
    Italy

    E F Coccaro
    Medical College of Pennsylvania
    Philadelphia, PA, USA

    J C Cookson
    Royal London Hospital
    London, UK

    H Dufour
    Clinique Psychiatrique Universitaire
    Lausanne, Switzerland

    H Emrich
    Max Planck Institute
    M¨¹nchen, Germany

    J P Feighner
    Feighner Research Institute
    Poway, CA, USA

    S Garattini
    Instituto di Richerche Farmacologiche
    Milan, Italy

    C-G Gottfries
    Saint Jorgen's Hospital
    Hisings-Backa, Sweden

    P Grof
    Royal Ottawa Hospital
    Ottawa, Ontario, Canada
    I Hindmarch
    University of Surrey
    Guildford, UK

    L Hollister
    University of Texas
    Houston, TX, USA

    T Itil
    New York University Medical Center
    New York, USA

    D King
    The Queen's University of Belfast
    Northern Ireland

    B Leonard
    University College
    Galway, Ireland

    O Lingjaerde
    Gaustad Hospital
    Gaustad, Oslo, Norway

    J J L¨®pez-Ibor
    Universidad Complutense
    Madrid, Spain

    J Mendlewicz
    Erasme Hospital
    Brussels, Belgium

    R M Post
    National Institute of Mental Health
    Bethesda, MD, USA

    T Shibuya
    Tokyo Medical College
    Japan

    M Versiani
    Universidade Federal do Rio De Janeiro
    Brazil

    H Westenberg
    Academic Hospital
    Utrecht, The Netherlands

    Submission of Manuscripts:
    Manuscripts should be sent to the editor at the following address:
    Professor S A Montgomery
    International Clinical Psychopharmacology
    P.O. Box 8751
    London W13 8WH
    England
    Fax: +44 (0) 181 566 7986
    E-mail:
    ICP@montgomery.demon.co.uk


    Copyright © 2014 武汉大学图书馆 版权所有